The World Health Organization quality of life assessment (WHOQOL): Position paper from the World Health Organization
References (28)
Quality of Life Assessment: An Annotated Bibliography
(1994)- et al.
Aims and implementation of multi-centre studies
Modern Problems Pharmacopsychiat
(1981) - et al.
The SF-36 health survey: development and use in mental health research and the IQOLA project
Int. J. Mental Hlth
(1994) - et al.
The EORTC modular approach to quality of life assessment in oncology
Int. J. Mental Hlth
(1994) - et al.
Quality of life assessment across cultures
Int. J. Mental Hlth
(1994) The family scenario in a developing country and its implications for mental health: the case of India
Ensuring international equivalence of quality of life measures: problems and approaches to solution
- et al.
Translation of health status instruments
WHOQOL Study Protocol
(1993)Development of the WHOQOL: rationale and current status
Int. J. Mental Hlth
(1994)
The development of the World Health Organization quality of life assessment instrument (the WHOQOL)
Definitions and dimensions of quality of life
Quality of Life assessment in therapeutic trials: Rationale for and presentation of a more appropriate instrument
Fundamental Clin. Pharmac
Health Status and Health Policy: Allocating Resources to Health Care
Cited by (4426)
Virtual reality and electroencephalography in architectural design: A systematic review of empirical studies
2024, Journal of Building EngineeringThe effect of dance on mental health and quality of life of people with Parkinson's disease: A systematic review and three-level meta-analysis
2024, Archives of Gerontology and GeriatricsQuality of life and family management of paediatric chronic condition amidst the COVID-19 pandemic
2024, Journal of Pediatric NursingNiceness scale: Development and validation of self-reported behavioral niceness measure
2024, Personality and Individual Differences
- ∗
This paper was written by Dr Willem Kuyken on behalf of the WHOQOL Group. The WHOQOL group comprises a coordinating group, collaborating investigators in each of the field centres and a panel of consultants. Dr J. Orley directs the project. He has been assisted by Dr W. Kuyken, Dr N. Sartorius and Dr M. Power. In the field centres collaborating investigators are: Professor H. Herrman, Dr H. Schofield and Ms B. Murphy, University of Melbourne, Australia; Professor Z. Metelko, Professor S. Szabo and Mrs M. Pibernik-Okanovic, Institute of Diabetes, Endocrinology and Metabolic Diseases and Department of Psychology, Faculty of Philosophy, University of Zagreb, Croatia; Dr N. Quemada and Dr A. Caria, INSERM, Paris, France; Dr S. Rajkumar and Mrs Shuba Kumar, Madras Medical College, India; Dr S. Saxena, All India Institute of Medical Sciences, New Delhi, India; Dr D. Bar-On and Dr M. Amir, Ben-Gurion University, Beer-Sheeva, Israel; Dr Miyako Tazaki, Department of Science, Science University of Tokyo, Japan and Dr Ariko Noji, Department of Community Health Nursing, St Luke's College of Nursing, Japan; Dr G. van Heck and Mrs J. De Vries, Tilburg University, The Netherlands; Professor J. Arroyo Sucre and Professor L. Picard-Ami, University of Panama, Panama; Professor M. Kabanov, Dr A. Lomachenkov and Dr G. Burkovsky, Bekhterev Psychoneurological Research Institute, St. Petersburg, Russia; Dr R. Lucas Carrasco, Barcelona, Spain; Dr Yooth Bodharamik and Mr Kitikorn Meesapya, Institute of Mental Health, Bangkok, Thailand; Dr S. Skevington, University of Bath, United Kingdom; Dr D. Patrick, Ms M. Martin and Ms D. Wild, University of Washington, Seattle, U.S.A. and; Professor W. Acuda, Dr. J. Mutambirwa, University of Zimbabwe, Harare, Zimbabwe.
An international panel of consultants includes: Dr N. K. Aaronson, Dr P. Bech, Dr M. Bullinger, Dr He-Nian Chen, Dr J. Fox-Rushby, Dr C. Moinpour and Dr R. Rosser. Consultants who have advised WHO at various stages of the development of the project have included: Dr D. Buesching, Dr D. Bucquet, Dr L. W. Chambers, Dr B. Jambon, Dr C. D. Jenkins, Dr D. De Leo, Dr L. Fallowfield, Dr P. Gerin, Dr P. Graham, Dr O. Gureje, Dr K. Kalumba, Dr Kerr-Correa, Dr C. Mercier, Mr J. Oliver, Dr Y. H. Poortinga, Dr R. Trotter and Dr F. van Dam.
Technical support and funds have been provided by the World Health Organization, the participating centres themselves and by support from the Upjohn Company, Kalamazoo, U.S.A., the IPSEN Foundation, Paris, France and the Carnegie Corporation, New York.
Further information and cited WHO documents can be obtained from: The WHOQOL Group, Division of Mental Health, World Health Organization, CH-1211 Geneva 27, Switzerland.